As shown in Figure 12B, 0%, 14.89%, and 15.53% of efferocytosis genes were upregulated in ApoE–/– at 6 weeks, 32 weeks, and 78 weeks, respectively; PPE-AAA upregulated more efferocytosis genes (27.66%) than that of other AAA models; ApoE–/– Ang II-AAA at 7 days and 28 days upregulated more efferocytosis genes (29.79% and 17.02%) than that of 14 days. This evidence concerns the gene AGT and triple-A syndrome.